Bone Drug Slows Mets in Aggressive Prostate Ca - MedPage Today

Bone Drug Slows Mets in Aggressive Prostate Ca MedPage Today SAN FRANCISCO -- Denosumab (Xgeva) delays the onset of bone metastases for even the highest risk prostate cancer patients, researchers found. The relative benefit of denosumab on survival time compared with placebo was greatest in patients at highest ... and more »

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and ... - UroToday

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and ... UroToday Prostate cancer is the leading non-skin malignancy detected in US males and the second cause of death due to male cancer, in the US. Interventions with drugs or diet supplements that slow down the growth and progression of prostate cancer are ...